TRI-SUCCESS - Tricuspid Regurgitation Study of the Unica™ Cross-Caval System for the Evaluation of Efficacy and Safety in Significant TR Subjects

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 510 participants.

Also called NCT07919366

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 510 participants (planned count) (from the registry)
Sponsor
Innoventric LTD (from the registry)
Registry
  • NCT NCT07919366
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07919366. Randomized; no masking; primary purpose treatment. Start 2027-01-01 (anticipated); primary completion 2031-01-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
TRI-SUCCESS - Tricuspid Regurgitation Study of the Unica™ Cross-Caval System for the Evaluation of Efficacy and Safety in Significant TR Subjects
Acronym
TRI-SUCCESS
Condition
Tricuspid Regurgitation
Condition
Tricuspid Regurgitation Functional
Intervention (Device)
Innoventric Unica™ System
Lead sponsor
Innoventric LTD (class: industry)
Collaborator
Innoventric Inc. (class: not stated)

Record details

Record id
cardio:ct-nct07919366
Content hash
2638689810d5c6f4712a323942a5314afce4b8bfb629636527929c42d297a4c2